Financial Information for the Company and Its Subsidiaries (Tables)

9 Months Ended

Sep. 30, 2014

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Consolidating Balance Sheet

Condensed Consolidating Balance Sheet - September 30, 2014 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	123,829	$	25,270	$	44,982	$	—		$	194,081
Restricted cash and marketable securities	—		—		30,251		—			30,251
Accounts receivable, net	—		118,984		110,266		—			229,250
Supplies inventory	45		451		18,564		—			19,060
Prepaid and other current assets	46,467		68,766		12,108		978			128,319
Total current assets	170,341		213,471		216,171		978			600,961
Property and equipment, net	10,294		11,412		154,190		—			175,896
Investments in and receivables from unconsolidated affiliates	3,875,039		1,567,902		—		(5,369,815		)	73,126
Goodwill	—		1,469,197		—		1,834,621			3,303,818
Intangible assets, net	66,349		1,192,678		2,925		—			1,261,952
Other assets	2,831		1,780		2,991		(1,998		)	5,604
Total assets	$	4,124,854	$	4,456,440	$	376,277	$	(3,536,214	)	$	5,421,357
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	9,668	$	—		$	18,368
Accounts payable	3,493		—		25,148		(4,188		)	24,453
Accrued salaries and benefits	18,677		99,198		15,175		—			133,050
Accrued interest	18,697		—		20		—			18,717
Other accrued liabilities	5,132		45,536		9,198		(662		)	59,204
Total current liabilities	54,699		144,734		59,209		(4,850		)	253,792
Long-term debt	2,209,125		—		51,835		(30,646		)	2,230,314
Deferred income taxes	199,194		413,903		—		(1,999		)	611,098
Other long-term liabilities	7,160		52,862		32,044		—			92,066
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		62,259		114,257			176,516
Equity:
Total AmSurg Corp. equity	1,654,676		2,594,477		129,273		(2,723,750		)	1,654,676
Noncontrolling interests – non-redeemable	—		22,307		41,657		338,931			402,895
Total equity	1,654,676		2,616,784		170,930		(2,384,819		)	2,057,571
Total liabilities and equity	$	4,124,854	$	4,456,440	$	376,277	$	(3,536,214	)	$	5,421,357

Condensed Consolidating Balance Sheet - December 31, 2013 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	6,710	$	—	$	44,130	$	—		$	50,840
Accounts receivable, net	—		—		105,072		—			105,072
Supplies inventory	33		—		18,381		—			18,414
Prepaid and other current assets	27,090		—		13,971		(4,362		)	36,699
Total current assets	33,833		—		181,554		(4,362		)	211,025
Property and equipment, net	6,024		—		157,666		—			163,690
Investments in and receivables from unconsolidated affiliates	1,484,108		1,453,596		—		(2,922,178		)	15,526
Goodwill	—		—		—		1,758,970			1,758,970
Intangible assets, net	24,489		—		3,378		—			27,867
Other assets	866		—		—		—			866
Total assets	$	1,549,320	$	1,453,596	$	342,598	$	(1,167,570	)	$	2,177,944
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	10,714	$	—	$	10,130	$	—		$	20,844
Accounts payable	1,972		—		29,487		(3,958		)	27,501
Accrued salaries and benefits	21,115		—		11,179		—			32,294
Accrued interest	1,847		—		38		—			1,885
Other accrued liabilities	4,457		—		3,293		(404		)	7,346
Total current liabilities	40,105		—		54,127		(4,362		)	89,870
Long-term debt	561,429		—		53,246		(31,377		)	583,298
Deferred income taxes	176,020		—		—		—			176,020
Other long-term liabilities	7,569		—		17,934		—			25,503
Noncontrolling interests – redeemable	—		—		63,704		113,993			177,697
Equity:
Total AmSurg Corp. equity	764,197		1,453,596		114,671		(1,568,267		)	764,197
Noncontrolling interests – non-redeemable	—		—		38,916		322,443			361,359
Total equity	764,197		1,453,596		153,587		(1,245,824		)	1,125,556
Total liabilities and equity	$	1,549,320	$	1,453,596	$	342,598	$	(1,167,570	)	$	2,177,944

Condensed Consolidating Statement of Operations

Condensed Consolidating Statement of Operations - For the Three Months Ended September 30, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Revenues	$	5,551		$	221,013	$	281,472		$	(4,803	)	$	503,233
Operating expenses:
Salaries and benefits	14,961			153,653		72,094			(123		)	240,585
Supply cost	—			816		41,425			—			42,241
Other operating expenses	6,424			19,127		60,661			(4,680		)	81,532
Transaction costs	23,111			1,991		—			—			25,102
Depreciation and amortization	790			12,320		7,756			—			20,866
Total operating expenses	45,286			187,907		181,936			(4,803		)	410,326
Equity in earnings of unconsolidated affiliates	58,649			48,225		—			(104,716		)	2,158
Operating income	18,914			81,331		99,536			(104,716		)	95,065
Interest expense, net	23,864			14,631		560			—			39,055
Debt extinguishment costs	16,887			—		—			—			16,887
Earnings (loss) from continuing operations before income taxes	(21,837		)	66,700		98,976			(104,716		)	39,123
Income tax expense (benefit)	(8,442		)	8,051		409			—			18
Net earnings (loss) from continuing operations	(13,395		)	58,649		98,567			(104,716		)	39,105
Net earnings (loss) from discontinued operations	3,561			—		(5,243		)	—			(1,682		)
Net earnings (loss)	(9,834		)	58,649		93,324			(104,716		)	37,423
Net earnings attributable to noncontrolling interests	—			—		47,257			—			47,257
Net earnings (loss) attributable to AmSurg Corp. shareholders	(9,834		)	58,649		46,067			(104,716		)	(9,834		)
Preferred stock dividends	(2,239		)	—		—			—			(2,239		)
Net earnings (loss) attributable to AmSurg Corp. common shareholders	$	(12,073	)	$	58,649	$	46,067		$	(104,716	)	$	(12,073	)
Amounts attributable to AmSurg Corp. common shareholders:
Earnings (loss) from continuing operations, net of income tax	$	(15,634	)	$	58,649	$	50,997		$	(104,716	)	$	(10,704	)
Discontinued operations, net of income tax	3,561			—		(4,930		)	—			(1,369		)
Net earnings (loss) attributable to AmSurg Corp. common shareholders	$	(12,073	)	$	58,649	$	46,067		$	(104,716	)	$	(12,073	)

Condensed Consolidating Statement of Operations - For the Nine Months Ended September 30, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Revenues	$	18,042		$	221,013	$	818,007		$	(14,189	)	$	1,042,873
Operating expenses:
Salaries and benefits	44,728			153,653		209,235			(369		)	407,247
Supply cost	—			816		120,576			—			121,392
Other operating expenses	15,440			19,127		171,264			(13,820		)	192,011
Transaction costs	26,690			1,991		—			—			28,681
Depreciation and amortization	2,429			12,320		22,871			—			37,620
Total operating expenses	89,287			187,907		523,946			(14,189		)	786,951
Gain on deconsolidation	3,411			3,411		—			(3,411		)	3,411
Equity in earnings of unconsolidated affiliates	161,340			150,916		—			(308,795		)	3,461
Operating income	93,506			187,433		294,061			(312,206		)	262,794
Interest expense, net	36,658			14,630		1,621			—			52,909
Debt extinguishment costs	16,887			—		—			—			16,887
Earnings from continuing operations before income taxes	39,961			172,803		292,440			(312,206		)	192,998
Income tax expense	16,687			8,051		1,134			—			25,872
Net earnings from continuing operations	23,274			164,752		291,306			(312,206		)	167,126
Net earnings (loss) from discontinued operations	3,048			—		(4,465		)	—			(1,417		)
Net earnings	26,322			164,752		286,841			(312,206		)	165,709
Net earnings attributable to noncontrolling interests	—			—		139,387			—			139,387
Net earnings attributable to AmSurg Corp. shareholders	26,322			164,752		147,454			(312,206		)	26,322
Preferred stock dividends	(2,239		)	—		—			—			(2,239		)
Net earnings attributable to AmSurg Corp. common shareholders	$	24,083		$	164,752	$	147,454		$	(312,206	)	$	24,083
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	$	21,035		$	164,752	$	151,988		$	(312,206	)	$	25,569
Discontinued operations, net of income tax	3,048			—		(4,534		)	—			(1,486		)
Net earnings attributable to AmSurg Corp. common shareholders	$	24,083		$	164,752	$	147,454		$	(312,206	)	$	24,083

Condensed Consolidating Statement of Operations - For the Three Months Ended September 30, 2013 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Revenues	$	6,273		$	—	$	261,043	$	(4,281	)	$	263,035
Operating expenses:
Salaries and benefits	16,087			—		67,447		(118		)	83,416
Supply cost	—			—		37,360		—			37,360
Other operating expenses	5,427			—		53,759		(4,163		)	55,023
Transaction costs	110			—		—		—			110
Depreciation and amortization	847			—		7,392		—			8,239
Total operating expenses	22,471			—		165,958		(4,281		)	184,148
Equity in earnings of unconsolidated affiliates	50,969			50,969		—		(100,843		)	1,095
Operating income	34,771			50,969		95,085		(100,843		)	79,982
Interest expense	6,711			—		582		—			7,293
Earnings from continuing operations before income taxes	28,060			50,969		94,503		(100,843		)	72,689
Income tax expense	10,747			—		414		—			11,161
Net earnings from continuing operations	17,313			50,969		94,089		(100,843		)	61,528
Net earnings (loss) from discontinued operations	(542		)	—		1,281		—			739
Net earnings	16,771			50,969		95,370		(100,843		)	62,267
Net earnings attributable to noncontrolling interests	—			—		45,496		—			45,496
Net earnings attributable to AmSurg Corp. common shareholders	$	16,771		$	50,969	$	49,874	$	(100,843	)	$	16,771
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	$	17,313		$	50,969	$	49,220	$	(100,843	)	$	16,659
Discontinued operations, net of income tax	(542		)	—		654		—			112
Net earnings attributable to AmSurg Corp. common shareholders	$	16,771		$	50,969	$	49,874	$	(100,843	)	$	16,771

Condensed Consolidating Statement of Operations - For the Nine Months Ended September 30, 2013 (In thousands)
	Parent Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Revenues	$	17,449		$	—	$	776,137	$	(12,872	)	$	780,714
Operating expenses:
Salaries and benefits	45,940			—		197,995		(348		)	243,587
Supply cost	—			—		112,329		—			112,329
Other operating expenses	15,483			—		156,332		(12,524		)	159,291
Transaction costs	285			—		—		—			285
Depreciation and amortization	2,379			—		21,773		—			24,152
Total operating expenses	64,087			—		488,429		(12,872		)	539,644
Gain on deconsolidation	2,237			2,237		—		(2,237		)	2,237
Equity in earnings of unconsolidated affiliates	153,850			153,850		—		(305,507		)	2,193
Operating income	109,449			156,087		287,708		(307,744		)	245,500
Interest expense	20,661			—		1,685		—			22,346
Earnings from continuing operations before income taxes	88,788			156,087		286,023		(307,744		)	223,154
Income tax expense	34,532			—		1,183		—			35,715
Net earnings from continuing operations	54,256			156,087		284,840		(307,744		)	187,439
Net earnings (loss) from discontinued operations	(1,111		)	—		4,048		—			2,937
Net earnings	53,145			156,087		288,888		(307,744		)	190,376
Net earnings attributable to noncontrolling interests	—			—		137,231		—			137,231
Net earnings attributable to AmSurg Corp. common shareholders	$	53,145		$	156,087	$	151,657	$	(307,744	)	$	53,145
Amounts attributable to AmSurg Corp. common shareholders:
Earnings from continuing operations, net of income tax	$	54,256		$	156,087	$	149,593	$	(307,744	)	$	52,192
Discontinued operations, net of income tax	(1,111		)	—		2,064		—			953
Net earnings attributable to AmSurg Corp. common shareholders	$	53,145		$	156,087	$	151,657	$	(307,744	)	$	53,145

Condensed Consolidating Statement of Cash Flows

Condensed Consolidating Statement of Cash Flows - For the Nine Months Ended September 30, 2014 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	103,091		$	225,098		$	309,033		$	(361,171	)	$	276,051
Cash flows from investing activities:
Acquisitions and related transactions	(2,147,585		)	(2,142,611		)	1,574			2,149,974			(2,138,648		)
Acquisition of property and equipment	(3,653		)	(2,337		)	(17,119		)	—			(23,109		)
Proceeds from sale of interests in surgery centers	—			4,969			—			—			4,969
Purchases of marketable securities	—			—			(3,486		)	—			(3,486		)
Other	(2,555		)	(648		)	5,285			—			2,082
Net cash flows used in investing activities	(2,153,793		)	(2,140,627		)	(13,746		)	2,149,974			(2,158,192		)
Cash flows from financing activities:
Proceeds from long-term borrowings	2,040,000			—			6,399			—			2,046,399
Repayment on long-term borrowings	(394,318		)	—			(8,725		)	—			(403,043		)
Distributions to owners, including noncontrolling interests	—			(206,580		)	(294,034		)	361,171			(139,443		)
Capital contributions	—			2,147,585			—			(2,147,585		)	—
Proceeds from preferred stock offering	172,500			—			—			—			172,500
Cash dividends for preferred shares	(2,239		)	—			—			—			(2,239		)
Proceeds from common stock offering	439,875			—			—			—			439,875
Payments of equity issuance costs	(24,366		)	—			—			—			(24,366		)
Financing cost incurred	(65,673		)	—			—			—			(65,673		)
Changes in intercompany balances with affiliates, net	731			—			(731		)	—			—
Other financing activities, net	1,311			(206		)	2,656			(2,389		)	1,372
Net cash flows provided by (used in) financing activities	2,167,821			1,940,799			(294,435		)	(1,788,803		)	2,025,382
Net increase in cash and cash equivalents	117,119			25,270			852			—			143,241
Cash and cash equivalents, beginning of period	6,710			—			44,130			—			50,840
Cash and cash equivalents, end of period	$	123,829		$	25,270		$	44,982		$	—		$	194,081

Condensed Consolidating Statement of Cash Flows - For the Nine Months Ended September 30, 2013 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	29,083		$	153,382		$	314,172		$	(247,704	)	$	248,933
Cash flows from investing activities:
Acquisitions and related transactions	—			(59,899		)	—			444			(59,455		)
Acquisition of property and equipment	(3,264		)	—			(17,447		)	—			(20,711		)
Proceeds from sale of interests in surgery centers	—			151			—			—			151
Other	107			—			—			—			107
Net cash flows used in investing activities	(3,157		)	(59,748		)	(17,447		)	444			(79,908		)
Cash flows from financing activities:
Proceeds from long-term borrowings	122,200			—			7,235			—			129,435
Repayment on long-term borrowings	(141,403		)	—			(10,273		)	—			(151,676		)
Distributions to owners, including noncontrolling interests	—			(94,322		)	(290,463		)	247,704			(137,081		)
Changes in intercompany balances with affiliates, net	1,899			—			(1,899		)	—			—
Other financing activities, net	(11,620		)	688			778			(444		)	(10,598		)
Net cash flows used in financing activities	(28,924		)	(93,634		)	(294,622		)	247,260			(169,920		)
Net increase (decrease) in cash and cash equivalents	(2,998		)	—			2,103			—			(895		)
Cash and cash equivalents, beginning of period	7,259			—			39,139			—			46,398
Cash and cash equivalents, end of period	$	4,261		$	—		$	41,242		$	—		$	45,503